SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

HIKAL

BSE: 524735 22 Aug 2025
Healthcare
₹ 255.05
Hikal Ltd. specializes in Pharmaceuticals within the Healthcare sector.

HIKAL - Share Price & Details

Market Cap
₹3,148
High /Low
465.0 / 247.0
Stock P/E
49.7
Book Value
₹102.0
Dividend Yield
0.57
ROCE
9.87
ROE
₹7.41
Face Value
2.0
PEG Ratio
-2.88
EVEBITDA
₹12.9
Debt
765
CMP / FCF
67.5
Debt to equity
₹0.61
NP Ann
90.8
High price all time
742.0
Piotroski score
₹7.0
Graham Number
109.0
No. Eq. Shares
12.3
Net CF
₹0.30
Net profit
63.3
Price to book value
2.47
Interest Coverage
₹2.19
Low price all time
15.8
Industry PE
32.8
Reserves
₹1,238
Free Cash Flow
₹144

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
HIKAL LTD.3814.0-227.03804.0-1.843,14849.7
VIMTA LABS LTD.993.13188.94975.644.21296048.6
IOL CHEMICALS & PHARMACEUTICAL5590.6339.65516.91.16284127.0

Peer Comparison Chart


About HIKAL

Hikal Ltd., with Security Code 524735, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Policy changes make India a global Pharma powerhouse, says Hikal Vice Chairman and Managing Director Hiremath

(18 Aug 2025)
Hikal Ltd. VP discusses India's rise in pharmaceutical contract manufacturing, projecting significant growth in global market share.
Read more →

The Price Is Right For Hikal Limited (NSE:HIKAL) Even After Diving 25%

(14 Aug 2025)
NSEI:HIKAL 1 Year Share Price vs Fair Value Explore Hikal's Fair Values from the Community and select yours To the...
Read more →

Hikal (NSE:HIKAL) Has Announced That It Will Be Increasing Its Dividend To ₹0.80

(10 Aug 2025)
Hikal Limited ( NSE:HIKAL ) has announced that it will be increasing its dividend from last year's comparable payment...
Read more →

Hikal reports Q1 FY26 consolidated loss of Rs. 22.4 Cr

(08 Aug 2025)
Hikal Limited has reported consolidated financial results for the period ended June 30, 2025. Hikal has posted net loss of Rs. 23 crores for...
Read more →

Pharma firm Hikal Limited swings into loss of Rs 22.4 crore in Q1

(08 Aug 2025)
Mumbai, Aug 7 (IANS) Life sciences company Hikal Limited on Thursday reported a net loss of Rs 22.4 crore for the quarter ended June 30 (Q1...
Read more →

Hikal Ltd (BOM:524735) Q1 2026 Earnings Call Highlights: Navigating Challenges and Seizing ... By GuruFocus

(08 Aug 2025)
Hikal Ltd (BOM:524735) Q1 2026 Earnings Call Highlights: Navigating Challenges and Seizing ...
Read more →

Company Updates